An official website of the United States government
Home
Name
ABT 888
Alternate Names
Veliparib
Abbreviations
None
Category
Chemotherapy
Subcategory
PARP Inhibitor
NSC Number
None
Primary Site
Ovary
Histology
None
Remarks
Dec. 2013: received FDA approval to treat patients with advanced ovarian cancer. this drug is also in clinical trials for metastatic unresectable solid tumors and Non-Hodgkin lymphoma.
Coding
This drug should be coded
